AbbVie to present HCV data in November AbbVie (ABBV +1.9%) will present new HCV data at AASLD in November.Investors will get a look at SVR12 data from PEARL-1 and additional analyses from AVIATOR. Worth remembering: ABT-450 was discovered in collaboration with Enanta (ENTA